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Using Patchxpress to Screen Blockers of the Cardiac Sodium Channel
(Nav1.5) for Effects on Late INA, Peak INA, and Channel Kinetics
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The Nav1.5 channel is responsible for the upstroke of the action potential in
cardiac myocytes. Congenital mutations in hNav1.5 have been shown to impair
fast inactivation, leading to an increase in persistent sodium current (late INa)
and LQT3. Growing evidence suggests that an increase in late INa can contrib-
ute to the pathogenesis of several cardiac diseases. With the goal of finding
small molecules that selectively target cardiac late INa over peak INa and
have rapid unbinding kinetics, we developed three novel assays on PatchXpress
using HEK-293 cells stably expressing hNav1.5. The first assay measures block
of late INa generated by tefluthrin, a pyrethroid that impairs fast inactivation.
We chose tefluthrin over another late INa activator, the sea anemone toxin
ATX-II, because with tefluthrin late INa reaches steady state faster and more
reliably. Importantly, block obtained with tefluthrin and ATX-II is usually sim-
ilar. The second assay measures tonic and use-dependent block of peak INa
stimulated at 0.1 Hz and 3 Hz, respectively. To reduce voltage clamp errors
on PatchXpress due to large inward peak currents and access resistance, we
used 50% series resistance compensation and reduced Naþ in the extracellular
solution to 20 mM. The third assay is designed to determine the rate at which
compounds dissociate from the channel and is calculated from the time-course
of the decrease in peak INa when the stimulation frequency is reduced from 10
to 1 Hz. All three assays on PatchXpress were validated by comparing IC50s or
off-rates for several standard Nav1.5 blockers (eg. flecainide, mexiletine, quin-
idine and lidocaine) to those obtained from manual patch clamp. IC50s agree
within two-fold and off-rate rankings are identical.
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Nora Lenkey1, Robert Karoly1, Peter Lukacs1, E. Sylvester Vizi1,
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A comparative electrophysiological study of 43 drugs was carried out using
rNav1.2 expressing HEK 293 cells and the QPatch automatic patch-clamp in-
strument. IC50 values were calculated for all drugs, and for the 35 drugs which
caused substantial inhibition of sodium channels, onset/offset kinetics, revers-
ibility and use-dependence were also determined. Based on these properties,
sodium channel inhibitor drugs could be classified into distinct types. We
have observed that properties of inhibition correlated with chemical properties,
and that categories based on properties of inhibition often concurred with ther-
apeutic categories. For example, a subset of antidepressants (tricyclic com-
pounds and selective serotonin reuptake inhibitors) inhibited sodium channels
in a special way (with high affinity, slow kinetics, poor reversibility and use
dependence), which was clearly different from the inhibition caused by classic
sodium channel inhibitors (low affinity, fast kinetics, and good reversibility).
Recording multiple properties of inhibition did not make our measurements
more costly or time consuming, but provided additional information. By the
help of this extra information, we have established that sodium channel inhib-
itors are heterogeneous, delineated specific types of inhibition, and observed
correlations both with chemical properties and therapeutic profile that would
be hidden if the IC50 alone was determined.
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Light Control of Cell Excitability Using a Photochromic Blocker for
Voltage-Gated Ion Channels
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Rendering proteins light sensitive gives the opportunity to control various cel-
lular functions with great spatial and temporal precision. Native proteins can
be photosensitized using photochromic ligands (PCLs), small light sensitive
molecules that can be reversibly converted between active and inactive forms
with light. We engineered a new PCL for voltage-gated ion channels, QAQ,
which consists of an Azobenzene photoswitch flanked by two Quaternary am-
moniums. Azobenzenes rapidly photoisomerize between cis and trans configu-rations upon 380 or 500 nm light irradiation, respectively. Quaternary ammo-
niums are internal blockers for voltage-gated sodium, potassium and calcium
channels. Our studies show that intracellular QAQ blocks indiscriminitely
those three types of ion channels in its trans state, while photoisomerization
to the cis configuration relieves block.
QAQ is a permanently charged, membrane-impermeable molecule that needs
hydrophilic pathways to reach its site of action. Loading QAQ into neurons
through a patch pipette can be used to control excitability of sub-cellular domains
in a single cell. More importantly, QAQ can be loaded into multiple cells at
a time, passing through open TRPV1 or P2X7 receptors, two non-selective cat-
ion channels that show pore-dilation upon prolonged activation. Experiments
in HEK cells and hippocampal neurons show that QAQ can enter cells only
upon expression AND activation of TRPV1 or P2X7R. QAQ can also be loaded
into cells naturally expressing those channels, like the sensory neurons of the
dorsal root ganglia that play a crucial role in pain sensation. QAQacts like a local
anesthetic, silencing sensory neurons by blocking voltage-gated cation channels.
In this context, light can then be used to restore nociception. QAQ is therefore
a very promising PCL molecule with both scientific and clinical applications.
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ducing Phyllobates aurotaenia Poison Dart Frog Resistant to BTX?
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Batrachotoxin is a potent toxin found in skins of Phyllobates frogs. The skeletal
muscle Naþ channels of Phyllobates aurotaenia frogs have been proposed to
be resistant to high concentrations of BTX (>1mM). In order to unravel the
mechanism and structural elements that confer BTX-resistance toP. aurotaenia,
we cloned its skeletal muscle Naþ channel, PaNaV1.4. As reported last year,
PaNaV1.4 has high homology (>70%) with other NaV1.4 channels especially
in the membrane spanning regions. Some residues that have been identified in
mutagenesis studies as critical for BTX-channel interaction in mammalian
NaV are conserved inPaNaV1.4. To further address the issue, we have expressed
PaNaV1.4 inXenopus laevis oocytes.We report here the functional characteriza-
tion of PaNaV1.4, studied under voltage-clamp, and its response to BTX.
PaNaV1.4 expresses robustly. While the general characteristics of the ionic
currents were similar, at room temperature PaNaV1.4 tended to open at more
depolarized voltages, inactivated faster and currents peaked earlier than
rNaV1.4. BTX, at concentrations as high as 10mM, had a significantly lower
effect on PaNaV1.4 currents than on rNaV1.4. The ratio of plateau to peak
currents at 80 mV was ~0.2-0.5 in PaNaV1.4 while >0.95 in rNaV1.4. BTX
modification of PaNaV1.4 occurred at a slow rate. Both activation thresholds
were negatively shifted. Because most of the residues proposed to participate
in the BTX effect are located in the pore lining segment (S6) of NaV, we have
also studied Pa/rNaV1.4 hybrid channels with domains, S6 segments or resi-
dues swapped or exchanged.
Supported by COLCIENCIAS1106-12-13836 (LF), AHA 0725763Z (WS), and
NIH GM030376 (FB) and GM068044 (AMC).
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MolecularLinkBetweenVoltage-SensorModification andLocalAnesthetic
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Sodium channels are a major target for many toxins and drugs including local
anesthetics (LA). Gating current (Sheets and Hanck, J. Gen. Physiol.; 121(2),
2003) and fluorescence measurements (Muroi and Chanda, J. Gen. Physiol.;
133(1), 2009) show that LA binding to the pore mainly stabilizes the volt-
age-sensor of domains III of sodium channel in an upward (activated) con-
formation. The half maximal (V1/2) of the fluorescence-voltage (F-V) curves
of probes attached to the voltage-sensor of domain III are left shifted by as
much as 50 mV upon LA binding. To address the molecular basis of stabiliza-
tion of the activated S4 upon LA binding, we systematically introduced trypto-
phan (or alanine) residues in the S4-S5 linker, N-terminal of S5 and C-terminal
of S6 of the domain III muscle sodium channel. We examined the effect of
these substitutions by voltage-clamp fluorimetry and by gating current mea-
surements. Mutations of specific residues on the S4-S5 linker and C-terminal
of the S6 segment significantly reduced or eliminated the shifts in the F-V curve
upon LA binding. Furthermore, the total gating charge in the presence of LA
remained unchanged in these mutants. These findings may provide insight
into the structure and interactions of intermediate states during the sodium
channel gating process.
Support: National Institutes of Health, AHA and Shaw Scientific Award
